Inspire Medical Systems, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US4577301090
USD
95.27
-23 (-19.45%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Inspire Medical Systems, Inc. stock-summary
stock-summary
Inspire Medical Systems, Inc.
Pharmaceuticals & Biotechnology
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the developing and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. The Company has developed a novel, closed-loop solution that continuously monitors a patient's breathing patterns and delivers mild hypoglossal nerve stimulation to maintain an open airway. The system delivers mild stimulation to the hypoglossal nerve, which controls the movement of user's tongue and other key airway muscles. By stimulating these muscles, the airway remains open during sleep. The system is controlled by a small handheld sleep remote.
Company Coordinates stock-summary
Company Details
5500 Wayzata Blvd Ste 1600 , GOLDEN VALLEY MN : 55416-1237
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 130 Schemes (81.0%)

Foreign Institutions

Held by 221 Foreign Institutions (21.12%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Ms. Marilyn Nelson
Independent Chairman of the Board
Mr. Timothy Herbert
President, Chief Executive Officer, Director
Ms. Shelley Broader
Director
Ms. Georgia Garinois-Melenikiotou
Director
Mr. Gary Ellis
Independent Director
Dr. Jerry Griffin
Independent Director
Mr. Shawn McCormick
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
217 Million
(Quarterly Results - Jun 2025)
Net Profit:
-4 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 2,471 Million (Small Cap)

stock-summary
P/E

60.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.44

stock-summary
Return on Equity

8.43%

stock-summary
Price to Book

3.65